Status:
ACTIVE_NOT_RECRUITING
Immunogenicity of Concomitant Administration of COVID-19 Vaccines With Influenza Vaccines
Lead Sponsor:
Catholic Kwandong University
Collaborating Sponsors:
Korea University Guro Hospital
Conditions:
COVID-19
Influenza
Eligibility:
All Genders
18-65 years
Phase:
PHASE4
Brief Summary
The goal is to evaluate the in-depth immunogenicity analysis (including B-cell and T-cell response) of coadministration of a omicron-containing COVID-19 vaccine and influenza vaccine among healthy adu...
Detailed Description
This was an open-label, randomized clinical trial conducted at the International St. Mary's Hospital in Incheon, South Korea. This study included two study groups: Concomitant administration of omicro...
Eligibility Criteria
Inclusion
- who agreed to receive both booster COVID-19 vaccine and influenza vaccine
- individuals who have received the COVID-19 vaccine three or more times and have passed at least 3 months after the last vaccination
- individuals with a history of a single SARS-CoV-2 infection during the Omicron outbreak period (January 2022-February 2023)
Exclusion
- individuals with a contraindication to any of the vaccine compounds
- individuals with a history of influenza infection within the past 6 months
Key Trial Info
Start Date :
September 25 2023
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
June 25 2025
Estimated Enrollment :
62 Patients enrolled
Trial Details
Trial ID
NCT06091410
Start Date
September 25 2023
End Date
June 25 2025
Last Update
March 26 2024
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Korea University Guro Hospital
Seoul, Guro-gu, South Korea, 08308
2
International St. Mary's hospital
Incheon, Seo-gu, South Korea, 22711